A low-dose, portal dihydrotestosterone implant has a sustained effect to improve glycaemic control and provides cardiovascular and renal protection in a large animal model of type 2 diabetes
Year: 2025
Type: conference-paper
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7124518880
FWCI:
Cites:
Cited by:
Related to:
